Companies: 10,795·Total market cap: $144.5T
Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc.

PLPLOTCFinancial Services● Active
$0.00
+$0.00(+900.00%)
Market Cap$4488953
P/E Ratio
52W High$0.0001
52W Low$0.00001
Overview
Foreign Private Issuer · Files 20-F / 6-K

Plandaí Biotechnology, Inc. (PLPL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001317880 · PLPL · OTC · as of Jun 9, 2026

Filing snapshot

199
Total Filings
10-Q
Latest Form
2023-03-20
Most Recent
1995
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001317880 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-16
Fiscal Year End
Mar 16, 2023
Accession No.
0001829126-23-002070
Primary Document
plandai_10k.htm
Source: data.sec.gov · CIK 0001317880 · Accession 0001829126-23-002070

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
FORM 8-K
2016-09-21Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2023-03-20
View
10-KAnnual Report
10-K
2023-03-16
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 6 TO SCHEDULE 13G
2022-02-15
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO.1 TO SCHEDULE 13G
2021-01-27
View
SC 13GBeneficial Ownership Report
SCHEDULE 13G
2021-01-21
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO.4 TO SCHEDULE 13G
2020-02-13
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 3 TO SCHEDULE 13G
2019-02-15
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2018-02-14
View
SC 13G/ABeneficial Ownership Report (Amended)
SCHEDULE 13G/A2
2017-04-24
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2017-02-01
View
15-12G15-12G
FORM 15-12G
2017-01-31
View
NT 10-KNT 10-K
NT 10-K
2016-09-28
View
SC 13GBeneficial Ownership Report
SC 13G
2016-09-27
View
8-KCurrent Report
FORM 8-K
2016-09-21
View
SC 13GBeneficial Ownership Report
SCHEDULE 13G
2016-09-01
View
Showing 1–15 of 193 filingsForm 4 / 144 hidden· 199 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001317880  |  Exchange: OTC · Financial Services

Plandaí Biotechnology, Inc. (OTC: PLPL) has submitted 199 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1995. As a Financial Services sector company with CIK 0001317880, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Plandaí Biotechnology, Inc.'s most comprehensive regulatory disclosure. The most recent Plandaí Biotechnology, Inc. 10-K was filed on 2023-03-16 for fiscal year ending 2023. Historical PLPL 10-K annual reports are available from 2005 through 2023.

Investors researching Plandaí Biotechnology, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

PLPL SEC Filings · 8 questions

Plandaí Biotechnology, Inc. (PLPL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 199 filings and access original documents at no cost. Plandaí Biotechnology, Inc.'s CIK is 0001317880.

PLPL SEC filingsPlandaí Biotechnology, Inc. SEC documentsfind PLPL 10-K